Isodine 10%

Quick links to important sections

Isodine 10%

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Isodine 10%

Property Description
Active ingredient Povidone-iodine (PVP-I)
Form Aqueous Solution
Pharmacological class Antiseptic, Broad-spectrum microbicide
General purpose Surface disinfection and microbial control
Origin Synthetic complex

What is Isodine 10% and What Type of Medicine is It?

Isodine 10% is classified as a topical antiseptic and disinfectant solution, belonging to the broad-spectrum microbicide pharmacological class. Its fundamental purpose is providing effective microbial control and sanitation when applied to the skin or superficial tissue. The product is typically available Over-the-Counter (OTC), supporting its use in immediate minor first aid situations.

The drug’s general role is established by its single active ingredient, Povidone-iodine (PVP-I), which acts to reduce the presence of a wide range of harmful microorganisms, including bacteria, viruses, fungi, and spores, at the application site. Povidone-iodine is recognized for its strong microbicidal effect across a spectrum of pathogens. This means the solution reliably helps to eliminate germs on the surface where it is used, which is critical when, for example, cleansing a minor cut or abrasion.

Composition and Form: The Povidone-Iodine Complex

The medicine is supplied as a single-active ingredient aqueous solution designed strictly for topical administration. The core component, Povidone-iodine, is a synthetic complex that is formed when the polymer polyvinylpyrrolidone (PVP) is chemically bound to elemental iodine. The specific 10% concentration noted refers to the percentage of the Povidone-iodine complex contained within the overall formulation.

Povidone-iodine is a stable chemical complex that slowly releases iodine. This complexation is essential to the product’s identity, as the PVP acts as a carrier, stabilizing the iodine and ensuring its slower, safer delivery to the skin's surface via the water-based solvent. This formulation is often differentiated from simple iodine solutions by its reduced staining capacity and lower local irritation potential.

Regulatory References

  1. United States National Library of Medicine

What side effects are possible with Isodine 10%?

Official Safety Profile of Isodine 10% (Povidone-Iodine)

Official regulatory documents classify the possible effects of Povidone-iodine primarily into local adverse reactions and rare systemic reactions resulting from iodine absorption. The safety profile is defined by frequency and the body system affected, adhering to government-mandated frameworks.

Adverse Reaction Classifications

Common effects are limited to the application site, most often involving local skin irritation or transient skin discoloration (staining). These are expected and are the most frequently reported adverse reactions listed in regulatory safety documentation.

Rare and Serious Reactions involve systemic exposure and are categorized within specific System-Organ Classes (SOC), including the Immune System, Endocrine, and Renal systems. Officially documented serious reactions include anaphylactic reaction (a severe, rare systemic allergic response), and systemic iodine toxicity. The label also notes the risk of severe local tissue injury such as chemical burns, particularly if the solution is allowed to pool.

Population-Specific Safety Considerations

The official labeling highlights safety constraints for specific patient groups due to their increased vulnerability to absorbed iodine. Use requires caution in individuals with pre-existing thyroid disorders. Regulatory authorities also specify an elevated risk for neonates and young infants due to their highly permeable skin and potential for developing transient hypothyroidism following application.

Exposure-Related Safety Constraints

Systemic adverse effects, such as metabolic disturbances, are generally linked to long-term repeated use or single applications over large, damaged skin areas, not short-term minor use. Furthermore, iodine absorption may temporarily interfere with thyroid function tests used in clinical assessment, a specific safety note included in official product information.

Overdose and Emergency Response

Overdose of Povidone-iodine (Isodine 10%) is primarily documented as systemic iodine toxicity resulting from accidental ingestion or excessive systemic absorption through large areas of compromised skin. When ingestion is suspected, regulators mandate that individuals seek immediate medical help or contact a Poison Control Center right away, and that vomiting should not be induced unless directed by a professional.

Documented Manifestations and Severe Outcomes

The official regulatory profile lists severe clinical manifestations, including acute gastrointestinal effects, profound hypotension leading to shock and circulatory collapse, and changes in neurological status such as stupor. Acute toxicity may further lead to life-threatening complications, including acute renal failure and laryngeal edema. Systemic iodine exposure is also officially documented as potentially causing severe thyroid axis disruption, resulting in hypo- or hyperthyroidism.

Management and Specific Considerations

The official guidance states that no specific antidote is available for iodine poisoning; therefore, clinical treatment is restricted to being symptomatic and supportive. Specific overdose considerations exist for vulnerable populations: neonates and infants are at risk of hypothyroidism, and patients with pre-existing renal impairment or thyroid disease may experience heightened or specific toxic effects.

Therapeutic Uses of Isodine 10%

What Isodine 10% Treats: Main Uses and Benefits

Povidone-iodine is applied when appropriate for skin disinfection in first aid and clinical settings. It is generally used to provide antiseptic treatment across specific superficial conditions.

Antiseptic Management of Minor Skin Injuries

Povidone-iodine is commonly used in acute first aid to provide essential antiseptic support for minor cuts, scrapes, abrasions, and small superficial burns, which are conditions characterized by periods of heightened symptoms related to physical discomfort. The primary therapeutic benefit assists with broad-spectrum microbial control, supporting the reduction of germ presence at the injury site and helping prevent localized infection.

Infection Risk Reduction in Clinical and Pre-Procedural Settings

The solution is also considered relevant in clinical settings for proactively reducing infection risk through appropriate skin preparation. It is applied to skin prior to medical procedures, where its microbial control assists with lowering the presence of pathogens that could potentially be introduced into tissues. This is used across therapeutic domains where additional symptomatic support in infection prevention is needed.

“The primary benefit assists with broad-spectrum microbial control, supporting the reduction of germ presence at the injury site.”


Quick Fact: Relief for Microbial Contamination

Povidone-iodine is applied in scenarios where short-term symptomatic assistance is needed for symptoms related to inflammatory or irritative states caused by surface germs, assisting with maintaining functional stability during the early healing phase.

Regulatory References

  1. NIH DailyMed overview

Eligibility and Restrictions for Use

Who can and cannot use Isodine 10%?

Isodine 10% (Povidone-iodine) is approved for use by adults for general topical antiseptic purposes. Regulatory documents define specific population-based restrictions and absolute contraindications primarily related to the risk of systemic iodine absorption.

The medicine is contraindicated and must not be used by individuals with a known hypersensitivity to iodine or Povidone. Use is strictly prohibited in patients with manifest hyperfunction of the thyroid (hyperthyroidism) or other severe thyroid diseases, as well as those undergoing or scheduled for radioactive iodine therapy.

Age-related restrictions are critical: The solution is contraindicated in new-borns and small infants (e.g., typically under two years of age) due to the high risk of iodine-induced hypothyroidism.

Use is conditional and restricted for pregnant and breastfeeding individuals; it should be used only if strictly indicated and limited to the absolute minimum application and duration. Caution is also advised for patients with impaired renal function and those with pre-existing thyroid conditions like goiter or thyroid nodules, where prolonged or widespread use must be avoided.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Povidone-iodine is primarily defined by strict regulatory restrictions related to chemical incompatibility and systemic absorption of iodine.

Interaction Classification Interacting Substances/Products
Formal Contraindications Lithium (systemic therapy) and Mercury derivatives are strictly prohibited due to potential potentiation of thyroid-suppressing effects and caustic complex formation, respectively. Tissue-engineered products are also contraindicated due to chemical degradation.
Pharmacodynamic Interference Co-administration must be avoided with other antiseptic agents (like those containing Octenidine, Silver, or Hydrogen Peroxide) and enzymatic wound preparations, as this often results in the inactivation or weakening of either substance.
Procedural Restrictions Povidone-iodine must not be used prior to or immediately following radioiodine diagnostic procedures or therapy, as absorbed iodine interferes with accurate test results, requiring a mandatory separation interval of up to four weeks.

The product's oxidative nature can cause false-positive results when used concurrently with certain diagnostic tests for components like glucose or hemoglobin in stool or urine samples. Furthermore, regulatory documents specify that neonates, pre-term infants, and patients with pre-existing thyroid disorders are populations with increased susceptibility to iodine absorption, which may lead to officially documented transient thyroid dysfunction. The official profile dictates adherence to these restrictions to prevent chemical antagonism and systemic interference.

Mechanism of Action

The microbicidal action of Povidone-iodine is mediated by the strong chemical activity of free elemental iodine ( I2), which is continuously released from its polyvinylpyrrolidone (PVP) carrier complex. This mechanism relies on direct chemical destruction, not specific biological receptor interactions.

Broad-Spectrum Oxidative Attack on Microbial Structures

The free iodine acts as a strong oxidizing agent, chemically targeting and irreversibly modifying essential microbial macromolecules, including proteins (especially those with -SH and -NH2 groups), lipids in cell membranes, and nucleic acids (DNA/RNA). This widespread molecular damage causes rapid destruction of the structural integrity and functional machinery across all major classes of pathogens.

Mechanistic Cascade for Cellular Collapse

Following penetration, the highly reactive I2 initiates a simultaneous assault that shuts down metabolic pathways, particularly those necessary for cellular respiration and ATP synthesis. This cascade results in the irreversible loss of viability and subsequent cellular disintegration, leading to a significant reduction of the microbial load at the application site.

️ Constraints Due to Organic Load Scavenging

This mechanism is chemically constrained because the active I2 is readily consumed, or scavenged, by oxidizable organic material (e.g., blood, pus, tissue debris). This consumption directly limits the concentration of active iodine available for interaction with the microorganisms.

Dosage and Administration Information

How to Use Isodine 10%: Administration Guidelines

The usage of Povidone-iodine 10% aqueous solution is characterized by specific application route, frequency, and duration patterns. This medicine is designated exclusively for topical application to the skin and must never be administered internally.

Standard Application Patterns

The dosing regimen for this solution is situational rather than fixed. For the antiseptic management of minor cuts, scrapes, and burns, the solution is typically applied full strength to the affected area. The standard frequency pattern specifies application 1 to 3 times daily. When used for pre-operative skin preparation in a clinical setting, the application is usually a single, focused administration.

Procedural Constraints and Duration:

Usage Instruction Domain Requirement
Preparation The application site should be cleaned before the solution is applied.
Drying Time The solution must be allowed to dry completely prior to covering the area (e.g., with bandages or surgical drapes).
Duration Limit Use for minor injuries should be limited to no longer than 7 days unless otherwise directed by a healthcare professional.

Population-Specific Use

Use in children under 12 years of age is conducted with guidance from a healthcare provider. Furthermore, application is generally avoided over large areas of the body, and special caution is required when used on newborns or infants due to the potential for systemic absorption.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Isodine 10%


Evidence for use in Type 2 Diabetes Mellitus

Research exploring the use of this agent in Type 2 Diabetes Mellitus has primarily involved Randomized Controlled Trials (RCTs) and meta-analyses. These studies monitored several key measures in adults, including changes in a long-term blood sugar measure called glycated hemoglobin (A1C), fasting blood sugar, body weight, and blood pressure. Studies report how symptoms evolved in the observed populations, reporting the measured changes in A1C and fasting blood sugar levels compared to baseline. What remains uncertain is the complete understanding of how all reported non-glycemic changes are related. Long-term outcomes following cessation regarding the reported blood sugar measurements are not fully established, and evidence is limited for certain smaller patient groups, such as those with severe liver or kidney conditions.


Evidence for use in Chronic Weight Management

The evidence landscape for chronic weight management mainly involves short- to intermediate-term Randomized Controlled Trials (RCTs). These studies was evaluated in adults categorized as having obesity or being overweight with a related health issue. Researchers monitored outcomes related to weight, such as the absolute and percentage change in body weight and Body Mass Index (BMI). These studies describe patterns observed where measurements in average body weight and BMI in the active groups showed changes compared to those in the comparator groups. The long-term effects are not fully established when treatment is extended beyond one to two years, and there is limited information available about the maintenance of the reported body weight changes once the treatment is stopped.


Evidence for the Reduction of Cardiovascular Risk

This area of research was evaluated in large-scale Cardiovascular Outcomes Trials (CVOTs). These trials are specifically designed to monitor the incidence of serious events, including Major Adverse Cardiovascular Events (MACE) (a composite of cardiovascular death, non-fatal heart attack, and stroke). The studies was studied for adults who had Type 2 Diabetes, particularly those with existing heart disease or multiple cardiovascular risk factors. These findings describe patterns related to the incidence of MACE, and also monitored other outcomes like hospitalization for heart failure. Evidence is limited concerning the reported patterns in the patient groups studied, and these results apply only to the populations studied.

Frequently Asked Questions (FAQ)

Common questions about Isodine 10% (FAQ)

Q: Can Isodine 10% be used on pets like cats or dogs for minor injuries?

A: Povidone-iodine is an antiseptic commonly used in veterinary medicine for first aid on minor cuts and wounds in animals. However, this product is generally intended for human use. Its use in animals should be discussed with a veterinarian to ensure appropriate application.

Q: Is it safe to apply Isodine 10% to deep puncture wounds or animal bites?

A: Official product warnings advise that users should consult a doctor or healthcare provider before applying this product to deep puncture wounds, animal bites, or serious burns. Consulting a doctor is important because official warnings advise against self-treating deep puncture wounds or bites.

Q: Can Isodine 10% be used on burns, and if so, what kind of burns?

A: The product is indicated for use as a first aid antiseptic to prevent infection in minor cuts, scrapes, and burns. If the burn is severe, it is important to seek immediate medical attention from a healthcare professional, as the product is not intended for serious burns.

Q: What happens if Isodine 10% accidentally gets in the eyes or is swallowed?

A: The product label states that contact with the eyes should be avoided during application. If the solution accidentally gets in the eyes, the labeling advises rinsing immediately. If the product is swallowed (ingested), professional medical help or contact with a Poison Control Center should be sought immediately.

Q: Why do some people use dilute povidone-iodine as a mouth gargle, and is Isodine 10% suitable for this?

A: Povidone-iodine is effective against many pathogens that cause mouth and throat infections, and it is available in specific products formulated as a gargle. However, Isodine 10% solution is strictly for topical use on the skin as an antiseptic and is not intended or approved for internal uses such as a mouth gargle.

Q: What research supports the use of povidone-iodine as a broad-spectrum antiseptic?

A: Povidone-iodine is recognized by health organizations globally and has been extensively studied for its antiseptic properties. Studies affirm its broad-spectrum efficacy—meaning it works against a wide range of harmful microorganisms including bacteria, viruses, fungi, and spores—and is used as a standard choice for surface disinfection in healthcare settings.

Q: Is Isodine 10% effective against antibiotic-resistant bacteria like MRSA?

A: Studies on povidone-iodine have shown it possesses rapid and strong bactericidal activity against antibiotic-resistant strains, including Methicillin-Resistant Staphylococcus aureus (MRSA). Studies suggest that because its mechanism of action is chemical and non-specific, it retains effectiveness against bacterial strains that have developed resistance to common antibiotics.

Q: Is it normal to feel a temporary drying sensation after using Isodine 10%?

A: Yes, dry skin and mild local skin irritation have been reported as common effects associated with the topical application of povidone-iodine. These effects are generally temporary and usually resolve quickly after the application.

Q: Is there a risk of developing iodine toxicity from using Isodine 10% topically?

A: The risk of systemic iodine toxicity is generally not observed with short-term, minor use. However, systemic absorption of iodine can occur with prolonged use or application over large areas of broken skin, which is why official labeling advises caution for vulnerable populations like neonates or those with pre-existing kidney or thyroid conditions.

Q: Can Isodine 10% be used to treat skin conditions other than wounds?

A: The product is labeled specifically as a first-aid antiseptic for minor cuts, scrapes, and burns. While povidone-iodine may be studied for or used in other conditions, any use for non-labeled conditions requires consultation with a healthcare professional.

Q: What is the difference between an antiseptic like Isodine 10% and an antibiotic?

A: An antiseptic like Isodine 10% is a chemical applied to the skin or superficial tissue to reduce the number of germs present locally. An antibiotic is a medication, often taken orally or injected, that is absorbed into the body to fight bacterial infections internally.

Q: Does washing the application area too soon after applying Isodine 10% reduce its effect?

A: While the label does not detail what happens if washed too soon, it is recommended that the solution be allowed to dry completely on the skin before being covered or exposed to water. This instruction is intended to ensure the product has time to complete its antiseptic action.

Q: Why is povidone-iodine often preferred over simple iodine tincture?

A: The povidone-iodine complex was developed to offer the strong germ-killing power of iodine with improved tolerance. It is often preferred over simple iodine solutions because it generally causes less skin irritation and results in less staining of the surrounding tissues.

Q: Can Isodine 10% be used to treat blisters, or should they be left alone?

A: Isodine 10% may be used as a general first-aid antiseptic for minor abrasions and, if a blister is broken, it can be used to disinfect the area to prevent infection. For intact blisters, it is a common practice to leave them unopened.

Q: Why is Isodine 10% generally not recommended for very long-term use?

A: Official labeling advises limiting the use of the product for minor injuries to no longer than 7 days unless otherwise directed by a healthcare provider. This restriction is primarily to minimize the risk of prolonged systemic exposure to iodine, which can interfere with the thyroid.

Q: Can Isodine 10% be used on the hair or scalp for antiseptic purposes?

A: Povidone-iodine is a standard component of pre-operative skin preparation in clinical settings, which often involves treating skin areas near the scalp. Outside of this surgical context, its general use is for topical application to the skin for first aid antiseptic purposes.

Q: What should I look for to know if the wound is getting worse despite using Isodine 10%?

A: The product label advises stopping use and consulting a doctor if the condition persists or worsens, or if redness, swelling, or irritation develops and lasts for more than 72 hours. These signs suggest the need for professional medical assessment.

Q: Does the efficacy of Isodine 10% change with temperature or light exposure?

A: The official storage requirements instruct users to protect the product from light and store it at controlled room temperature while avoiding freezing. Proper storage is necessary to help maintain the product's integrity and quality.

Q: What is the difference between Isodine 10% and other common antiseptics like rubbing alcohol or hydrogen peroxide?

A: Isodine 10% contains Povidone-iodine, which has a different chemical structure and germ-killing mechanism than alcohol or hydrogen peroxide. Povidone-iodine offers a broad-spectrum microbicidal action (against bacteria, viruses, and fungi) and is often formulated to be less irritating than simple iodine solutions.

Q: Is Isodine 10% used for preventing infection or just treating existing wounds?

A: The product is labeled for use as a first aid antiseptic to help prevent infection in minor cuts, scrapes, and burns. Its purpose is to reduce the microbial load on the skin's surface to minimize the chance of pathogens entering the body through the wound.

Q: Does Isodine 10% have properties against viruses and fungi, or only bacteria?

A: Studies and official information indicate that the active ingredient, Povidone-iodine, is a broad-spectrum microbicide effective against a wide range of harmful organisms, including bacteria, viruses, fungi, and spores.

Q: How long does it typically take for Isodine 10% to start working on a wound?

A: Povidone-iodine works through a rapid chemical destruction process by oxidizing microbial cells. This mechanism of action is extremely fast, indicating that the germ-killing effect begins very rapidly upon contact with microorganisms.

Q: What are the most common non-serious side effects people experience with Isodine 10%?

A: The most frequently reported and common non-serious effects involve the application site, including local skin irritation and transient skin discoloration (staining).

Q: Is redness or mild irritation at the application site a common side effect?

A: Yes, local skin irritation and redness at the application site are frequently reported and are classified as common expected effects when using this topical antiseptic.

Q: Is it normal for Isodine 10% to cause a temporary yellow or brown stain on the skin?

A: Yes, it is common for the solution to cause transient skin discoloration, resulting in a yellow or brown stain on the application site. This is a normal, expected effect of the povidone-iodine.

Q: Will the staining from Isodine 10% eventually wash off completely?

A: The discoloration is classified as transient; it is expected to be temporary and is generally removed by washing the area with water and soap or fades over time as the iodine complex is released.

Q: Is there a maximum length of time Isodine 10% should be used on a wound?

A: For minor cuts and scrapes, the official label specifies that use should be limited to no longer than 7 days unless a healthcare provider directs otherwise. This limit is set to minimize the risk of prolonged systemic exposure to iodine.

Q: Is the brown color of the solution an indicator of its effectiveness?

A: The brown color is a characteristic property of the povidone-iodine solution. While a change in the color or consistency of the solution may indicate degradation, the color itself is an indicator of the presence of the iodine complex.

How should Isodine 10% be stored and disposed of?

Official Storage and Disposal Requirements

Regulatory labeling dictates specific conditions for the safe storage and disposal of Isodine 10% (Povidone-Iodine).

Storage Conditions

Requirement Details
Temperature Store at controlled room temperature, typically below 25 C or 30 C.
Protection Protect from light and avoid freezing.
Container Keep the product in the original container with the cap tightly closed to maintain product integrity.
Safety The product must be kept out of the reach of children.

Handling and Disposal

Do not use the solution after the expiration date printed on the label. Disposal of unused or expired product and its container must be carried out in accordance with all local and national regulations. To comply with environmental requirements, the product must not be poured down the drain or released into public waterways or the general environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Isodine 10% found in:

A-Z Index: